Welcome to our dedicated page for AGILYSYS SEC filings (Ticker: AGYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AGILYSYS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AGILYSYS's regulatory disclosures and financial reporting.
AGILYSYS INC (AGYS) reported that Chief Financial Officer William David Wood III sold 6,000 shares of common stock on August 18, 2026. The sale was executed in the open market at a weighted average price of $114.72 per share, with individual trade prices ranging from $114.63 to $114.80. Following these transactions, Wood directly holds 35,052 shares of Agilysys common stock.
AGILYSYS INC (AGYS) reported that officer Kyle C. Badger, SVP, GC and Secretary, sold 8,400 shares of common stock on 2026-08-18 in an open market or private transaction. The weighted average sale price was about $114.06 per share, with actual prices ranging from $114.06 to $114.29. Following this sale, Badger directly holds 75,037 shares of AGILYSYS common stock.
AGILYSYS INC (AGYS) received a notice under Rule 144 for a planned sale of its common stock by officer William David Wood III. The notice lists 6,000 common shares in connection with a prospective sale through Fidelity Brokerage Services LLC, with an indicated date of 08/18/2026 and NASDAQ as the trading venue.
The filing details that the 6,000 shares relate to compensation awards, including a stock appreciation right dated 01/27/2023 and multiple restricted stock vesting events scheduled between 06/30/2024 and 10/31/2025. No sales in the past three months are reported in this notice.
AGILYSYS INC (AGYS) officer Kyle C. Badger filed a Rule 144 notice covering potential sales of common stock held through Fidelity Brokerage Services LLC. The filing reports beneficial ownership of 8,400 shares of AGYS common stock with an approximate market value of $958,112.66 as of August 18, 2026, listed on NASDAQ. It also notes that during the past three months, Badger sold 3,000 shares of AGYS common stock for $276,850.00 on June 10, 2026. Several equity compensation awards (stock appreciation rights and restricted stock vesting) are listed with their respective share amounts and vesting dates.
AGILYSYS INC reports that President & CEO Ramesh Srinivasan sold a total of 197,410 shares of common stock in open‑market or private transactions on August 5–7, 2026. The reported per‑share prices are weighted averages from $106.60 to $109.63, and an indirect holding of 60,000 shares is reported in the Ramesh and Sujatha Srinivasan Living Trust.
SRINIVASAN RAMESH reported acquisition or exercise transactions in this Form 4 filing.
Agilysys Inc reported two equity awards to President & CEO Ramesh Srinivasan on June 18, 2026, totaling 78,270 restricted stock units, each representing one share of common stock. One 39,135-unit grant vests over time starting June 18, 2028, while another 39,135-unit grant vests only if stock-price hurdles of $105, $120 and $135 are met over 20 consecutive trading days, followed by scheduled quarterly installments, all subject to continued employment.
RAMESH SRINIVASAN & SUJATHA SRINIVASAN JT TEN, holders of Agilysys (AGYS) common stock, filed to sell up to 25,000 shares through Morgan Stanley Smith Barney LLC on NASDAQ on 08/07/2026. These shares relate to restricted stock that vested on 06/10/2021 under a registered plan. The filing also notes prior sales of 40,000 shares over the past three months for $4,263,932.00 in aggregate proceeds.
Agilysys insider Ramesh Srinivasan filed a notice of proposed sale of 66,205 common shares of Agilysys, Inc. to be sold through Fidelity Brokerage Services LLC on or after August 6, 2026 on the NASDAQ market. The shares derive from equity compensation awards, including restricted stock vesting events in 2022, 2023 and 2024 and a stock appreciation right (SAR) in 2024. The filing also reports a sale of 66,205 common shares on August 5, 2026.
Agilysys, Inc. has a shareholder planning to sell up to 40,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The shares were acquired via restricted stock vesting under a registered plan dated June 10, 2021.
Agilysys, Inc. (AGYS) filed a notice of proposed sales of common stock. The plan covers 66,205 common shares to be sold through Fidelity Brokerage Services LLC on or after August 5, 2026 on the NASDAQ market, with an indicated aggregate market value of $7,257,802.34. Shares outstanding are listed as 28,205,788, a baseline figure, not the amount being sold.
The shares derive from equity compensation: 11,309 shares from restricted stock vesting dated March 10, 2025, 49,926 shares from stock appreciation rights (SAR) dated May 28, 2024, and 4,970 shares from restricted stock vesting dated May 21, 2025, each identified as compensation granted by the issuer.